CYP17 and tumor necrosis factor-α gene polymorphisms are associated with risk of oral cancer in Chinese patients in Taiwan

References

• D'Costa J, Saranath D, Dedhia P, Sanghvi V, Mehta AR. Detection of HPV-16 genome in human oral cancers and potentially malignant lesions from India. Oral Oncol 1998;34:413 —20.
   PubMedGoogle Scholar
• Sugerman PB, Shillitoe EJ. The high risk human papilloma-viruses and oral cancer: evidence for and against a causal relationship. Oral Dis 1997;3:130–47.
   PubMedGoogle Scholar
• Picado-Leonard J, Miller WL. Cloning and sequence of the human gene for P450c17 (steroid 17 a-hydroxylase/17,20 lyase): similarity with the gene for p450c21. DNA Cell Biol 1987;6: 439–48.
   Google Scholar
• Brentano ST, Picado-Leonard J, Mellon SH, Moore CCD, Miller WL. Tissue-specific cyclic adenosine 3', 5'-monopho-sphate-induced and phorbol ester-repressed transcription from the human P450c17 promoter in mouse cells. Mol Endocrinol 1990;4:1972–9.
   PubMed Web of Science ®Google Scholar
• Nedwin GE, Naylor SL, Sakaguchi AY, Smith D, Jarrett-Nedwin J, Pennica D, et al. Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization. Nucleic Acids Res 1985;13:6361–73.
   Google Scholar
• Wilson AG, di Giovine FS, Blakemore Al, Duff GW. Single base polymorphism in the human tumor necrosis factor-cc (TNF-c) gene detectable by Nco I restriction of PCR product. Hum Mol Genet 1992;1:353.
   PubMedGoogle Scholar
• Drummond SN, De Marco L, Pordeus Ide A, Barbosa AA, Gomez RS. TP53 codon 72 polymorphism in oral squamous cell carcinoma. Anticancer Res 2002;22:3379–81.
   PubMed Web of Science ®Google Scholar
• Yamazaki Y, Chiba I, Hirai A, Sugiura C, Notani K, Kashiwazaki H, et al. Specific p53 mutations predict poor prognosis in oral squamous cell carcinoma. Oral Oncol 2003;39:163 —9.
   PubMedGoogle Scholar
• Shwe M, Chiguchi G, Yamada S, Nakajima T, Maung KK, Takagi M, et al. P53 and MDM2 co-expression in tobacco and betel chewing-associated oral squamous cell carcinomas. J Med Dent Sci 2001;48:113–9.
   PubMedGoogle Scholar
• Nagpal JK, Patnaik S, Das BR. Prevalence of high-risk human papilloma virus types and its association with P53 codon 72 polymorphism in tobacco addicted oral squamous cell carcinoma (OSCC) patients of Eastern India. hit J Cancer 2002;97: 649–53.
   Google Scholar
• Hsieh LL, Wang PF, Chen IH, Liao CT, Wang HM, Chen MC, et al. Characteristics of mutations in the p53 gene in oral squamous cell carcinoma associated with betel quid chewing and cigarette smoking in Taiwanese. Carcinogenesis 2001;22:1497 —503.
   PubMedGoogle Scholar
• Tandle AT, Sanghvi V, Saranath D. Determination of p53 genotypes in oral cancer patients from India. Br J Cancer 2001;84: 739–42.
   Google Scholar
• Heinzel PA, Balaram P, Bernard HU. Mutations and polymorphisms in the p53, p21 and p16 genes in oral carcinomas of Indian betel quid chewers. hit J Cancer 1996;68: 420–3.
   Google Scholar
• Lin SC, Chang KW, Chang CS, Liu TY, Tzeng YS, Yang FS, et al. Alterations of p16/MTS1 gene in oral squamous cell carcinomas from Taiwanese. J Oral Pathol Med 2000;29:159–66.
   PubMedGoogle Scholar
• Gronau S, Koenig-Greger D, Jerg M, Riechelmann H. GSTM1 enzyme concentration and enzyme activity in correlation to the genotype of detoxification enzymes in squamous cell carcinoma of the oral cavity. Oral Dis 2003;9:62–7.
   PubMed Web of Science ®Google Scholar
• Buch SC, Notani PN, Bhisey RA. Polymorphism at GSTM1, GSTM3 and GSTT1 gene loci and susceptibility to oral cancer in an Indian population. Carcinogenesis 2002;23: 803–7.
   Google Scholar
• Sreelekha TT, Ramadas K, Pandey M, Thomas G, Nalina-kumari KR, Pillai MR. Genetic polymorphism of CYP1A1, GSTM1 and GSTT1 genes in Indian oral cancer. Oral Oncol 2001;37: 593–8.
   Google Scholar
• Galbraith GMP, Pandey JP. Tumor necrosis factor alpha (TNF-c) gene polymorphism in alopecia areata. Hum Genet 1995;96:433.
   PubMed Web of Science ®Google Scholar
• Patino-Garcia A, Sotillo-Pineiro E, Modesto C, Sierrasesu-maga L. Analysis of the human tumor necrosis factor-alpha (TNF-c) gene promoter polymorphism in children with bone cancer. J Med Genet 2000;37:789.
   PubMedGoogle Scholar
• Chiu CJ, Chiang CP, Chang ML, Chen HM, Hahn Hsieh LL, et al. Association between genetic polymorphism of tumor necrosis factor-alpha and risk of oral submucous fibrosis, a pre-cancerous condition of oral cancer. J Dent Res 2001;80:2055–9.
   PubMedGoogle Scholar
• Pindborg JJ, Murti PR, Bhonsle RB, Gupta PC, Daftary DK, Mehta FS. Oral submucous fibrosis as a precancerous condition. Scand J Dent Res 1984;92:224–9.
   PubMedGoogle Scholar
• Stanford JL, Noonan EA, Iwasaki L, Kolb S, Chadwick RB, Feng Z, et al. A polymorphism in the CYP17 gene and risk of prostate cancer. Cancer Epidemiol Biomarkers Prey 2002;11:243–7.
   PubMedGoogle Scholar
• Ntais C, Polycarpou A, Ioannidis JP. Association of the CYP17 gene polymorphism with the risk of prostate cancer: a meta-analysis [Review]. Cancer Epidemiol Biomarkers Prey 2003;12: 120–6.
   Google Scholar
• Haiman CA, Stampfer MJ, Giovannucci E, Ma J, Decalo NE, Kantoff PW, et al. The relationship between a poly-morphism in CYP17 with plasma hormone levels and prostate cancer. Cancer Epidemiol Biomarkers Prey 2001;10:743–8.
   PubMed Web of Science ®Google Scholar
• Habuchi T, Liqing Z, Suzuki T, Sasaki R, Tsuchiya N, Tachiki H, et al. Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene poly-morphism with a gene dosage effect. Cancer Res 2000;60:5710 —3.
   PubMedGoogle Scholar